Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Revenue

Handa Pharmaceuticals had revenue of 209.62M TWD in the quarter ending March 31, 2026, with 15.93% growth. This brings the company's revenue in the last twelve months to 1.76B, up 121.39% year-over-year. In the year 2025, Handa Pharmaceuticals had annual revenue of 1.73B with 108.17% growth.

• Revenue (ttm): 1.76B
• Revenue Growth: +121.39%
• P/S Ratio: 6.78
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.73B	898.58M	108.17%
Dec 31, 2024	830.67M	-275.65M	-24.92%
Dec 31, 2023	1.11B	908.64M	459.66%
Dec 31, 2022	197.68M	168.44M	576.16%
Dec 31, 2021	29.24M	376.00K	1.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error